Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
P/E ratio for Ambu A/S (AMBU-B.CO)
P/E ratio as of 2023: 114.52
According to Ambu A/S's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 114.52. At the end of 2022 the company had a P/E ratio of 181.39.
P/E ratio history for Ambu A/S from 2002 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 114.52 |
| 2022 | 181.39 |
| 2021 | 193.52 |
| 2020 | 184.15 |
| 2019 | 87.52 |
| 2018 | 114.65 |
| 2017 | 76.70 |
| 2016 | 67.55 |
| 2015 | 57.06 |
| 2014 | 33.35 |
| 2013 | 54.64 |
| 2012 | 15.00 |
| 2011 | 23.40 |
| 2010 | 18.95 |
| 2009 | 23.25 |
| 2008 | 17.21 |
| 2007 | 24.06 |
| 2006 | 23.18 |
| 2005 | 33.31 |
| 2004 | 13.73 |
| 2003 | 14.22 |
| 2002 | 24.67 |